J. Molner AS (TAL:MOLNR)

Estonia flag Estonia · Delayed Price · Currency is EUR
22.40
-0.60 (-2.61%)
At close: Jun 8, 2026
Market Cap37.77M -30.0%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out 1.69M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44
Open22.40
Previous Close23.00
Day's Range21.80 - 22.40
52-Week Range15.00 - 31.40
Beta0.29
Analystsn/a
Price Targetn/a
Earnings Daten/a

About J. Molner AS

J. Molner AS, a pharmaceutical company, focuses on the development and manufacturing of generic medicines in the United States, Canada, and Europe. The company develops and commercializes sterile injectable, ophthalmic, and dermatology generic drugs. It also offers drug development, analytical chemistry, and stability testing services. The company was founded in 2015 and is based in Tallinn, Estonia. [Read more]

Industry Commercial Physical and Biological Research
Founded 2015
Country Estonia
Stock Exchange Nasdaq Tallinn
Ticker Symbol MOLNR
Full Company Profile

News

J. Molner AS Quarterly report: H2 2025

J. Molner AS has published its H2 2025 quarterly earnings report on March 31, 2026.

2 months ago - Filings

J. Molner AS Quarterly report: H1 2025

J. Molner AS has published its H1 2025 quarterly earnings report on September 30, 2025.

9 months ago - Filings